Greet Beets

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial

Adriano Lazzarin, Thomas Campbell, Bonaventura Clotet et al. · The Lancet · 2007 · 392 citations

Treatment-experienced Hiv-1-infected Patients, Treatment And Prevention, Human Retrovirus +11

Dose-Ranging Phase 1 Study of TMC120, a Promising Vaginal Microbicide, in HIV-Negative and HIV-Positive Female Volunteers

Vicky Jespers, Jens M Van Roey, Greet Beets et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 57 citations

Single- and multiple-dose pharmacokinetics of etravirine administered as two different formulations in HIV-1-infected patients

Thomas N. Kakuda, Monika Schöller-Gyμre, Cassy Workman et al. · Antiviral Therapy · 2008 · 36 citations · Full text

Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus‐infected patients with decompensated liver disease

Eric Lawitz, Fred Poordad, Julio Gutiérrez et al. · Journal of Viral Hepatitis · 2016 · 31 citations · Full text

LP07 : Simeprevir (SMV) plus daclatasvir (DCV) and sofosbuvir (SOF) in treatment-naïve and -experienced patients with chronic hepatitis C virus genotype 1 or 4 infection and decompensated liver disease: Interim results from the phase II impact study

Eric Lawitz, Fred Poordad, Julio Gutiérrez et al. · Journal of Hepatology · 2015 · 13 citations

Hepatology, Hepatitis C, Viral Hepatitis +8